CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and ...

Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and preliminary efficacy of CTx001 as a potential one-time treatment for GA Opti-GAIN builds on insights from i-GAIN, a ...

At a cultural exhibition in Hotan in the Xinjiang Uygur autonomous region in mid-August, audiences watched in silence as polychromatic projections of the region's vibrant Atlas silk, famed for its ...

To give Ayurveda global recognition, India is placing special emphasis on evidence-based research and high-quality clinical trials through the Central Council for Research in Ayurvedic Sciences (CCRAS ...

The Pac-12 has undergone as bigger shuffle than any other as the conference-realignment era of college athletics has shaken up countless programs around the country. Oregon State and Washington State ...

Grammarly built its reputation on being a tool for checking spelling, grammar, and writing tips in English. The company is now expanding the scope of these features to support five more languages: ...

Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...

SAP announced its intent to acquire SmartRecruiters, a leading talent acquisition (TA) software provider, enabling the company to strengthen SAP’s all-in-one HCM suite, so customers have the tools ...

Our free DNA Reverse Complement tool is an indispensable utility for researchers, students, and technicians in molecular biology and genomics. Whether you’re designing PCR primers, verifying ...

Urban Sky develops small stratospheric balloons that can complement or replace satellites. Credit: Urban Sky WASHINGTON — Stratospheric ballooning company Urban Sky has won a contract from the U.S.

The historic Panama Grammar School, built in 1914, is back on the market for $1,750,000. The previous sale to a developer in 2021 fell through due to rising construction costs and uncertainty about ...